IGAN

Clinical trials for IGAN explained in plain language.

Never miss a new study

Get alerted when new IGAN trials appear

Sign up with your email to follow new studies for IGAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 3 Completed 1 Terminated 2

New drug shows promise for kidney disease in phase 2 trial

Disease control Completed

This study tested a new drug called VIS649 in 155 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Participants received either the drug or a placebo, and researchers monitored sid…

Matched conditions: IGAN

Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control

Last updated Jun 16, 2026 12:51 UTC

IGAN

Get alerted when new IGAN trials appear

New drug shows promise for kidney disease in phase 2 trial